Oncotarget’s original focus was to use oncology to eliminate or even prevent cancer from taking effects.
Oncotarget had begun in 2010 as a multidisciplinary journal with an initial focus with oncology, the science and the study of overall preventing diseases.
Although, Oncotarget’s methods were initially focused around fighting cancer cells as its primary focus, its methods have since been updated.
One updated method was that Oncotarget had focused around its core values around democratization. In other words, keeping the journal itself open and free to be used.
This demonstration of democratization from Oncotarget is shown through the implementation of Creative Commons Attribution 3.0 License.
Because of the Creative Commons Attribution 3.0 License, it enables researchers to actively share their research papers through the scientific community.
Because of this, more tests and experiments are able to finish more expediently.
Oncotarget was originally focused on the subject of oncology but as the journal began to grow and gain more influence and impact, it had also began to incorporate other adjacent topics such as chromosomes, autophagy, immunology, and other topics of interest.
With the outcome of the published papers being shared more easily, this has allowed for experiments to be conducted much more faster. Listen to Oncotarget podcast on Player.FM.
Progress on The Media Front for Oncotarget
While still growing and gaining influence as an active journal, Oncotarget had also been able to accomplish some of the goals that it had originally set forth before it in the media landscape.
An earlier stated objective that Oncotarget was looking to accomplish outright was increasing the weekly publication rate into a twice-weekly publication rate. This meant that readers of the publication would be receiving two issues both on Tuesday and on Friday.
The outcome would be a two-fold solution.
The first solution that resulted from is that readers are current to the knowledge that is happening in Oncotarget.
The second solution is that hiatuses and gaps are avoided. So, that’s a problem that readers would not have to worry about it.
The weekly-basis journal turning into a twice-weekly publication, Oncotarget had other goals in mind regarding podcasting.
The podcast’s purpose would have been to offer a more digestible for listeners to be able to hear about the breakthroughs from Oncotarget’s journal.
The length of the podcast’s episodes are less than ten minutes, generally, so the episodes are very easy and quick to listen to. This isn’t ignoring the fact that having a podcast makes the episode overall accessible. Learn more at researchgate.net
Listeners can listen to Oncotarget on Stitcher, Player. FM, Soundcloud, and iTunes.
Oncotarget’s Noteworthy Achievements
There are other accomplishments that Oncotarget have been a participant in.
Oncotarget has a impact factor score of 5.168, as evidence of the growing influence that the journal is having.
Another noteworthy accomplishment is that Oncotarget researchers have been able to identify proven new therapeutic strategies to treat thyroid cancer.
Oncotarget is still remaining indexed by most scientific databases such as Journal Citation Reports/Science Edition, Embase, BIOSIS Previews, and Biological Abstracts.
Oncotarget’s accomplishments have been rather noteworthy.
Preventing Diseases with Democratization
This is helped by the fact Oncotarget upholding its democratization principle with the management of their journal.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/